Background: Demodicosis is a chronic skin disease caused by parasitic mites of the genus Demodex. It usually affects the face area causing major esthetical problems. The pathogenesis of demodicosis is not fully understood; however, it is quite apparent that immunological mechanisms mediate its development. Objective: The goal of this study was to study the correlation between immunological and immunogenetic data obtained from patients with demodicosis in order to clarify the pathogenesis of Demodex infestation. Methods: Twenty-five patients with demodicosis and 13 age- and sex-matched healthy subjects participated in the study. The presence of mites was determined by microscopic inspection of sebum gland secretions. The immune response was evaluated by identifying membrane markers of different immune cells using monoclonal antibodies (anti-CD3+, CD4+, CD8+, CD16+, CD20+ and CD95+) while the concentration of IgA, IgM and IgG was measured by simple radial immunodiffusion. The level of circulating immune complexes and total hemolytic complement as well as the preparatory and digestive function of neutrophils and the functional activity of leukocytes were also studied. Patients were typed for HLA A, B, Bw and Cw using the microlymphocytotoxicity method. Results: The comparison between patients with and without the A2 phenotype showed that the latter have lower numbers of CD8+, lower functional activity of leukocytes, higher concentrations of IgA, larger affected skin areas and are more often affected by deep papular and papulopustular forms of demodicosis than those with the A2 phenotype, showing that this allele has a protective role in demodicosis. Patients exhibiting the Cw2 phenotypes were rather susceptible to demodicosis. They showed decreased numbers of CD3+, increased levels of phagocytic activity, higher mite density and severer skin damage as compared to patients lacking Cw2. Conclusions: The HLA A2 and Cw2 phenotypes have an important diagnostic, prognostic and pathogenetic significance and could play a role in resistance or susceptibility to demodicosis by regulating the end phase of the immune response.

Keywords:
Demodex mites, Demodicosis, human, Demodicosis pathogenesis, Immunology, Human leukocyte antigen phenotypes
1.
Rufli T, Mumcuoglu Y, Cajacob A, Buechner S: Demodex folliculorum: Zur Aetiopathogenese und Therapie der Rosacea und perioralen Dermatitis. Dermatologica 1981;162:12–26.
2.
Georgala S, Katoulis AC, Kylafis GD, Koumantaki-Mathioudaki E, Georgala C, Aroni K: Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol 2001;15:441–444.
3.
el-Shazly AM, Ghaneum BM, Morsy TA, Aaty HE: The pathogenesis of Demodex folliculorum (hair follicular mites) in females with and without rosacea. J Egypt Soc Parasitol 2001;31:867–875.
4.
Akilov OE, Mumcuoglu KY: Association between human demodicosis and HLA class I. Clin Exp Dermatol 2003;28:70–73.
5.
Buchner SA, Rufli T: T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica 1984;169: 1–5.
6.
Caswell JL, Yager JA, Parker WM, Moore PF: A prospective study of the immunophenotype and temporal changes in the histologic lesions of canine demodicosis. Vet Pathol 1997;34:279–287.
7.
Aydingoz IE, Mansur T, Dervent B: Demodex folliculorum in renal transplant patients. Dermatology 1997;195:232–234.
8.
de Jaureguiberry JP, Carsuzaa F, Pierre C, Arnoux D, Jaubert D: Demodex folliculitis: A cause of pruritus in human immunodeficiency virus infection. Ann Méd Interne (Paris) 1993;144:63–64.
9.
Redondo Mateo J, Soto Guzman O, Fernandez Rubio E, Dominguez Franjo F: Demodex-attributed rosacea-like lesions in AIDS. Acta Derm Venereol 1993;73:437.
10.
Barrio J, Lecona M, Hernanz JM, Sanchez M, Gurbindo MD, Lazaro P, Barrio JL: Rosacea-like demodicosis in an HIV-positive child. Dermatology 1996;192:143–145.
11.
Aquilina C, Viraben R, Sire S: Ivermectin-responsive Demodex infestation during human immunodeficiency virus infection. A case report and literature review. Dermatology 2002;205:394–397.
12.
Colbert RA: The immunobiology of HLA-B27:Variations on a theme. Curr Top Med Chem 2004;4:21–30.
13.
Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H: Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004;135:1–8.
14.
Olivo-Diaz A, Debaz H, Alaez C, Islas VJ, Perez-Perez H, Hobart O, Gorodezky C: Role of HLA class II alleles in susceptibility to and protection from localized cutaneous leishmaniasis. Hum Immunol 2004;65:255–261.
15.
Akilov O, Mumcuoglu K: Immune response in demodicosis. J Eur Acad Dermatol Venereol 2004;18:440–444.
16.
Roitt I, Brostoff J, Male D: Immunology. London, Mosby, 1998.
17.
Baksht BP: Role of the tick Demodex folliculorum hominis in human skin pathology. Vestn Dermatol Venerol 1965;39:31–36.
18.
Mancini G, Carbonara AO, Heremans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235–254.
19.
Grishchenko AM, Grinevich Iu A, Alferov AN, Redkousova SF, Sen’ko LN: Determination of the state of antitumor immunity and of serum blocking action in stomach cancer by using the leukocyte adherence inhibition reaction. Vrach Delo 1978:28–32.
20.
Kabat E, Mayer M: Experimental Immunochemistry. Springfield, Thomas, 1946.
21.
Reznikova LS: The Complement and Its Meaning in Immune Reactions. Moscow, Medizina, 1967.
22.
Olejnikova EA: The sensitivity of phagocyte activity of neutrophils in peripheral blood to tissue antigens as a feature of the autosensibility. Lab Delo 1978;3:164–168.
23.
Demin AA, Drobysheva VP: Spontaneous and levamisole-stimulated NBT test in systemic lupus erythematosus. Ter Arkh 1978;50:99–102.
24.
Terasaki PI, McClelland JD: Microdroplet assay of human serum cytotoxins. Nature 1964;204:998–1000.
25.
Liu Q, Arseculeratne C, Liu Z, Whitmire J, Grusby MJ, Finkelman FD, Darling TN, Cheever AW, Swearengen J, Urban JF, Gause WC: Simultaneous deficiency in CD28 and STAT6: Results in chronic ectoparasite-induced inflammatory skin disease. Infect Immun 2004;72:3706–3715.
26.
Girault C, Borsa-Lebas F, Lecomte F, Humbert G: Eruption papulo-nodulaire: démodécie au cours du syndrome d’immunodéficience acquise. Press Méd 1991;20:177.
27.
Powell FC: The histopathology of rosacea: ‘Where’s the beef?’ Dermatology 2004;209:173–174.
28.
Sarro RA, Hong JJ, Elgart ML: An unusual demodicidosis manifestation in a patient with AIDS. J Am Acad Dermatol 1998;38:120–121.
29.
Ayres S Jr, Ayres S 3rd: Demodectic eruptions (demodicidosis) in the human –30 years’ experience with 2 commonly unrecognized entities: Pityriasis folliculorum (Demodex ) and acne rosacea (Demodex type). Arch Dermatol 1961;83:816–827.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.